¼¼°èÀÇ ³²¿ë ¾à¹° °Ë»ç ½ÃÀå : ±âȸ ¹× Àü·«(-2034³â)
Drugs Of Abuse (DOA) Testing Global Market Opportunities And Strategies To 2034
»óǰÄÚµå : 1754828
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 325 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,138,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 8,872,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,606,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ³²¿ë ¾à¹° °Ë»ç ½ÃÀåÀº 2019³â 53¾ï 9,340¸¸ ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç, 2024³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 6.00% ÀÌ»óÀ» ³ªÅ¸³Â½À´Ï´Ù.

¾à¹° ³²¿ë »ç·Ê Áõ°¡

¿ª»çÀûÀÎ ±â°£ µ¿¾È ³²¿ë ¾à¹° °Ë»ç ½ÃÀå ¼ºÀåÀº ¾à¹° ³²¿ë »ç·Ê Áõ°¡¿¡ ÀÇÇØ °ßÀÎµÇ¾î ¿Ô½À´Ï´Ù. ¾à¹° ³²¿ë »ç°Ç Áõ°¡´Â Á¾Á¾ Á¤½Å À§»ý ¹®Á¦ÀÇ ½É°¢È­¿Í °ü·ÃµÇ¾î ÀÖ½À´Ï´Ù. ¸¹Àº »ç¶÷µéÀÌ ºÒ¾È, ¿ì¿ïÁõ ¶Ç´Â Á¤¼­Àû °íÅë°ú °°Àº »óÅ¿¡ ´ëóÇϱâ À§ÇØ ¿ÀÇÇ¿ÀÀ̵峪 ´ë¸¶ÃÊ¿Í °°Àº ¹°Áú¿¡ ÀÇÁ¸Çϱ⠶§¹®¿¡ ¾à¹° ³²¿ë »ç·ÊÀÇ Áõ°¡´Â Á¾Á¾ Á¤½Å °Ç°­ ¹®Á¦ÀÇ È®´ë¿Í °ü·ÃÀÌ ÀÖ½À´Ï´Ù. ¾à¹° ³²¿ë Å×½ºÆ®¿¡ ´ëÇÑ ¼ö¿ä´Â °í¿ëÁÖ, ÀÇ·á ¼­ºñ½º Á¦°øÀÚ, ¹ý ÁýÇà ±â°ü ¹× ±³À° ±â°üÀÌ ¾ÈÀü, ±ÔÁ¤ Áؼö ¹× °øÁß º¸°ÇÀ» À¯ÁöÇϱâ À§ÇØ ¾à¹° ¿À¿ëÀ» ¸ð´ÏÅ͸µ, °¨Áö ¹× ¿¹¹æÇØ¾ß ÇÒ Çʿ伺¿¡ ÀÇÇØ ÃËÁøµË´Ï´Ù. ¿¹¸¦ µé¾î, ¿µ±¹ Á¤ºÎ ºÎóÀÎ Åë°èû¿¡ µû¸£¸é 2023³â 3¿ù¿¡ 16¼¼¿¡¼­ 59¼¼ »çÀÌÀÇ ¾à 9.5%(¾à 310¸¸ ¸í)°¡ ¸¶¾àÀ» »ç¿ëÇß´Ù°í º¸°íÇß½À´Ï´Ù. ÀÌ Áß 7.6%(¾à 250¸¸ ¸í)´Â ´ë¸¶Ãʸ¦, 3.3%(¾à 110¸¸ ¸í)´Â A±Þ ¾à¹°À» »ç¿ëÇß´Ù°í ´äÇß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¸ñÂ÷

Á¦3Àå Ç¥ À϶÷

Á¦4Àå ±×¸² À϶÷

Á¦5Àå º¸°í¼­ ±¸¼º

Á¦6Àå ½ÃÀå Æ¯Â¡

Á¦7Àå ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦8Àå ¼¼°èÀÇ ³²¿ë ¾à¹° °Ë»ç ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦9Àå ¼¼°èÀÇ ³²¿ë ¾à¹° °Ë»ç ½ÃÀå : ¼¼ºÐÈ­

Á¦10Àå ³²¿ë ¾à¹° °Ë»ç ½ÃÀå : Áö¿ª ¹× ±¹°¡º° ºÐ¼®

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦12Àå ¼­À¯·´ ½ÃÀå

Á¦13Àå µ¿À¯·´ ½ÃÀå

Á¦14Àå ºÏ¹Ì ½ÃÀå

Á¦15Àå ³²¹Ì ½ÃÀå

Á¦16Àå Áßµ¿ ½ÃÀå

Á¦17Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦18Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦19Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦20Àå °æÀï º¥Ä¡¸¶Å·

Á¦21Àå °æÀï ´ë½Ãº¸µå

Á¦22Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦23Àå ¾à¹° ³²¿ë °Ë»ç ½ÃÀåÀÇ ÃÖ±Ù µ¿Çâ

Á¦24Àå ±âȸ¿Í Àü·«

Á¦25Àå ³²¿ë ¾à¹° °Ë»ç ½ÃÀå : °á·Ð°ú Á¦¾È

Á¦26Àå ºÎ·Ï

KTH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Drugs of Abuse (DOA) testing refers to the process of detecting the presence of illicit substances or misused prescription medications in an individual's system. This testing is utilized by various entities, including employers, law enforcement agencies, healthcare providers and educational institutions, to ensure safety, compliance with regulations and to provide appropriate medical interventions.

The drugs of abuse (DOA) testing market consists of sales, by entities (organizations, sole traders, or partnerships), of drugs of abuse (DOA) testing software and services used in workplaces, law enforcement, healthcare and rehabilitation programs to identify drug use, ensure compliance with regulations and support medical or legal decisions.

The global drugs of abuse (DOA) testing market was valued at $5,393.40 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 6.00%.

Rising Drug Abuse Cases

The growth of the drugs of abuse testing market during the historic period has been driven by the rising drug abuse cases. Drug abuse cases refer to situations where individuals excessively or improperly use substances such as illegal drugs, prescription medications, or other harmful substances, leading to physical, psychological, or social harm. Increasing drug abuse cases are often associated with escalating mental health issues, as many individuals resort to substances like opioids or cannabis to cope with conditions such as anxiety, depression, or emotional distress. The demand for drugs of abuse testing is propelled by the need for monitoring, detection, and prevention of substance misuse by employers, healthcare providers, law enforcement agencies, and educational institutions to maintain safety, compliance, and public health. For example, according to the Office for National Statistics, a UK-based government department, approximately 9.5% of individuals aged 16 to 59 years (around 3.1 million people) reported using drugs in the year ending March 2023. Among them, 7.6% reported cannabis use (around 2.5 million people), while 3.3% reported using Class A drugs (about 1.1 million people). Therefore, the increasing prevalence of drug abuse cases has significantly contributed to the expansion of the drugs of abuse testing market.

Revolutionizing Drug Testing With Mass Spec Solution For Enhanced Accuracy And Efficiency

Leading companies in the drugs of abuse testing market are focusing on developing innovative solutions, such as mass spec solutions, to enhance the accuracy, sensitivity, and speed of drug testing processes. Mass Spec solution in drugs of abuse testing refers to the use of mass spectrometry (MS) technology for detecting and quantifying drugs and their metabolites in various biological samples, such as blood, urine, saliva, and hair. For instance, in December 2024, Roche Holding AG, a Switzerland-based pharmaceutical company, launched its cobas Mass Spec solution, which has received CE mark approval, marking a significant milestone in making clinical mass spectrometry widely available. This solution includes the cobas i 601 analyzer and the first Ionify reagent pack, enabling automated and standardized testing for over 60 analytes, including steroid hormones, vitamin D metabolites, and drugs of abuse. By integrating various technologies into a single platform, Roche aims to enhance diagnostic accuracy and efficiency in routine laboratories, facilitating earlier detection of therapeutic changes in patients. The cobas Mass Spec solution is expected to transform clinical diagnostics by providing faster, more precise results, ultimately improving patient care worldwide.

The global drugs of abuse (DOA) testing market is concentrated, with large players operating in the market. The top ten competitors in the market made up to 43.59% of the total market in 2023.

Drugs Of Abuse (DOA) Testing Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global drugs of abuse (DOA) testing market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Where is the largest and fastest-growing market for drugs of abuse (DOA) testing? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The drugs of abuse (DOA) testing market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider drugs of abuse (DOA) testing market; and compares it with other markets.

The report covers the following chapters

Table of Contents

1 Executive Summary

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

7 Major Market Trends

8 Global Drugs Of Abuse (DOA) Testing Growth Analysis And Strategic Analysis Framework

9 Global Drugs Of Abuse (DOA) Testing Market Segmentation

10 Drugs Of Abuse (DOA) Testing Market, Regional and Country Analysis

11 Asia-Pacific Market

12 Western Europe Market

13 Eastern Europe Market

14 North America Market

15 South America Market

16 Middle East Market

17 Africa Market

18 Competitive Landscape And Company Profiles

19 Other Major And Innovative Companies

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

23 Recent Developments in the Drugs of Abuse Testing Market

24 Opportunities And Strategies

25 Drugs Of Abuse (DOA) Testing Market, Conclusions And Recommendations

26 Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â